we conclude that the syndrome of pseudohyperaldosteronism from carbenoxolone is thus probably not related to a direct agonist effect of the drug at the level of mineralocorticoid receptors , but that any action must follow in vivo conversion into glycyrrhetinic acid by hydrolysis .
C0006979
carbenoxolone
C0017986
glycyrrhetinic acid